CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Oxaliplatin with Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFOX 4) as First-line Therapy for Patients with Metastatic Colorectal Cancer
Hyuk-Chan Kwon, Kyoung Tae Kim, Shin Ae Lee, Jong-Sung Park, Sung-Hyun Kim, Jae-Seok Kim, Hyo Jin Kim
Cancer Research and Treatment. 2004;36(2):115-120.   Published online 2004 April 30    DOI: https://doi.org/10.4143/crt.2004.36.2.115

Excel Download

Oxaliplatin with Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFOX 4) as First-line Therapy for Patients with Metastatic Colorectal Cancer
Cancer Research and Treatment. 2004;36(2):115   Crossref logo
Link1 Link2

768 PUBLICATION Oxaloplatin with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX 4) as salvage therapy for patients with advanced gastric cancer
European Journal of Cancer Supplements. 2005;3(2):219   Crossref logo
Link1 Link2

Oxaliplatin with Biweekly Low Dose Leucovorin and Bolus and Continuous Infusion of 5-fluorouracil (Modified FOLFOX 4) as a Salvage Therapy for Patients w ith Advanced G astric Cancer
Cancer Research and Treatment. 2005;37(5):279   Crossref logo
Link1 Link2

3554 POSTER Phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (Modified FOLFOX-4) for gastric cancer patients with malignant ascites
European Journal of Cancer Supplements. 2007;5(4):275   Crossref logo
Link1 Link2

Cost-Effectiveness Analysis of First-Line Cetuximab Plus Leucovorin, Fluorouracil, and Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in Patients with RAS Wild-Type Metastatic Colorectal Cancer

Cancer Management and Research. 2019;Volume 11:10419-10426   Crossref logo
Link1 Link2

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study
Cancer Chemotherapy and Pharmacology. 1999;44(2):159-163   Crossref logo
Link1 Link2 Link3

Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Untreated Metastatic Colorectal Cancer: A North American Intergroup Trial
Yearbook of Oncology. 2008;2008:233-234   Crossref logo
Link1 Link2

Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen
Annals of Oncology. 1998;9(11):1251-1253   Crossref logo
Link1 Link2 Link3

Randomized Trial Comparing the Addition of Oxaliplatin or Irinotecan to High-Dose Leucovorin and 5-Fluorouracil Intravenous Bolus Every Two Weeks in Metastatic Colorectal Carcinoma: Southern Italy Cooperative Oncology Group 0103
Clinical Colorectal Cancer. 2003;3(3):186-189   Crossref logo
Link1 Link2

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer
International Journal of Cancer. 2010;128(3):682-690   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.